{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T19:12:04Z","timestamp":1681326724594},"reference-count":153,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.irn.2018.10.002","type":"book-chapter","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T02:47:26Z","timestamp":1541213246000},"page":"213-263","source":"Crossref","is-referenced-by-count":5,"title":["Imaging Transplantation in Movement Disorders"],"prefix":"10.1016","author":[{"given":"Edoardo Rosario","family":"de Natale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gennaro","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios","family":"Politis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Pt. 12","key":"10.1016\/bs.irn.2018.10.002_bb0010","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington's disease progression. PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"issue":"Pt. 6","key":"10.1016\/bs.irn.2018.10.002_bb0015","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","article-title":"Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease","volume":"119","author":"Antonini","year":"1996","journal-title":"Brain"},{"key":"10.1016\/bs.irn.2018.10.002_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/bs.pbr.2016.12.011","article-title":"From open to large-scale randomized cell transplantation trials in Huntington's disease: Lessons from the multicentric intracerebral grafting in Huntington's disease trial (MIG-HD) and previous pilot studies","volume":"230","author":"Bachoud-Levi","year":"2017","journal-title":"Progress in Brain Research"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: A long-term follow-up study","volume":"5","author":"Bachoud-Levi","year":"2006","journal-title":"Lancet Neurology"},{"issue":"9246","key":"10.1016\/bs.irn.2018.10.002_bb0030","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington's disease after neural transplantation","volume":"356","author":"Bachoud-Levi","year":"2000","journal-title":"Lancet"},{"issue":"Pt. 12","key":"10.1016\/bs.irn.2018.10.002_bb0035","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","article-title":"Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes","volume":"120","author":"Backman","year":"1997","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(12)70295-8","article-title":"Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease","volume":"12","author":"Barker","year":"2013","journal-title":"Lancet Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.002_bb0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/jnnp-2012-302441","article-title":"The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease","volume":"84","author":"Barker","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0050","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0006-8993(79)90472-4","article-title":"Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants","volume":"177","author":"Bjorklund","year":"1979","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/exnr.1999.7073","article-title":"Activation of neurotransplants in humans","volume":"158","author":"Bluml","year":"1999","journal-title":"Experimental Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.002_bb0060","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1073\/pnas.94.6.2569","article-title":"Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method","volume":"94","author":"Breier","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0065","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ana.410280412","article-title":"Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy","volume":"28","author":"Brooks","year":"1990","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-510X(99)00127-6","article-title":"The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease","volume":"166","author":"Broussolle","year":"1999","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0075","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00243848","article-title":"Behavioural effects of human fetal dopamine neurons grafted in a rat model of Parkinson's disease","volume":"65","author":"Brundin","year":"1986","journal-title":"Experimental Brain Research"},{"issue":"Pt. 7","key":"10.1016\/bs.irn.2018.10.002_bb0080","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/brain\/123.7.1380","article-title":"Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease","volume":"123","author":"Brundin","year":"2000","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12967-016-0880-2","article-title":"Finding a new therapeutic approach for no-option Parkinsonisms: Mesenchymal stromal cells for progressive supranuclear palsy","volume":"14","author":"Canesi","year":"2016","journal-title":"Journal of Translational Medicine"},{"issue":"Pt. 7","key":"10.1016\/bs.irn.2018.10.002_bb0090","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain"},{"issue":"8","key":"10.1016\/bs.irn.2018.10.002_bb0095","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archneur.56.8.997","article-title":"A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: Enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity","volume":"56","author":"Ceballos-Baumann","year":"1999","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2018.10.002_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1752-1947-8-87","article-title":"Treatment of progressive supranuclear palsy with autologous adipose tissue-derived mesenchymal stem cells: A case report","volume":"8","author":"Choi","year":"2014","journal-title":"Journal of Medical Case Reports"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.002_bb0105","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.parkreldis.2004.04.002","article-title":"Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's disease","volume":"10","author":"Chou","year":"2004","journal-title":"Parkinsonism & Related Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0110","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"Journal of Nuclear Medicine"},{"issue":"30","key":"10.1016\/bs.irn.2018.10.002_bb0115","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1073\/pnas.0904239106","article-title":"Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration","volume":"106","author":"Cicchetti","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"8","key":"10.1016\/bs.irn.2018.10.002_bb0120","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mds.10463","article-title":"Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue","volume":"18","author":"Cochen","year":"2003","journal-title":"Movement Disorders"},{"issue":"Suppl. 3","key":"10.1016\/bs.irn.2018.10.002_bb0125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00415-009-5242-z","article-title":"Lack of functional relevance of isolated cell damage in transplants of Parkinson's disease patients","volume":"256","author":"Cooper","year":"2009","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10495-011-0679-9","article-title":"Neuroprotective effects of human mesenchymal stem cells on neural cultures exposed to 6-hydroxydopamine: Implications for reparative therapy in Parkinson's disease","volume":"17","author":"Cova","year":"2012","journal-title":"Apoptosis"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.10.002_bb0135","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0006-8993(94)90526-6","article-title":"The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: Neural transplantation and developmental evidence","volume":"668","author":"Deacon","year":"1994","journal-title":"Brain Research"},{"issue":"3\u20134","key":"10.1016\/bs.irn.2018.10.002_bb0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(83)90150-4","article-title":"Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington's disease by day 18 fetal striatal implants","volume":"93","author":"Deckel","year":"1983","journal-title":"European Journal of Pharmacology"},{"issue":"11","key":"10.1016\/bs.irn.2018.10.002_bb0145","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.parkreldis.2013.06.014","article-title":"Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients","volume":"19","author":"dell'Aquila","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s00259-008-0989-5","article-title":"Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls","volume":"36","author":"Eshuis","year":"2009","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/bs.irn.2018.10.002_bb0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1196\/annals.1392.025","article-title":"Modulation of immune responses by mesenchymal stem cells","volume":"1106","author":"Fibbe","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0160","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00006231-200505000-00005","article-title":"123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms","volume":"26","author":"Filippi","year":"2005","journal-title":"Nuclear Medicine Communications"},{"issue":"22","key":"10.1016\/bs.irn.2018.10.002_bb0165","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199211263272202","article-title":"Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease","volume":"327","author":"Freed","year":"1992","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/bs.irn.2018.10.002_bb0170","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1056\/NEJM200103083441002","article-title":"Transplantation of embryonic dopamine neurons for severe Parkinson's disease","volume":"344","author":"Freed","year":"2001","journal-title":"The New England Journal of Medicine"},{"issue":"25","key":"10.1016\/bs.irn.2018.10.002_bb0175","doi-asserted-by":"crossref","first-page":"13877","DOI":"10.1073\/pnas.97.25.13877","article-title":"Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology","volume":"97","author":"Freeman","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.410380307","article-title":"Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease","volume":"38","author":"Freeman","year":"1995","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0185","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2217\/rme.10.3","article-title":"Stem cell-derived dopamine neurons for brain repair in Parkinson's disease","volume":"5","author":"Fricker-Gates","year":"2010","journal-title":"Regenerative Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1531-8249(20010201)49:2<155::AID-ANA35>3.0.CO;2-9","article-title":"Functional correlates of pallidal stimulation for Parkinson's disease","volume":"49","author":"Fukuda","year":"2001","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0195","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.20564","article-title":"Positron emission tomography after fetal transplantation in Huntington's disease","volume":"58","author":"Furtado","year":"2005","journal-title":"Annals of Neurology"},{"issue":"Pt 1","key":"10.1016\/bs.irn.2018.10.002_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/awh003","article-title":"Striatal neural grafting improves cortical metabolism in Huntington's disease patients","volume":"127","author":"Gaura","year":"2004","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0205","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/bs.irn.2018.10.002_bb0210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1479-5876-12-14","article-title":"Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: Translation into a phase I controlled, randomized clinical study","volume":"12","author":"Giordano","year":"2014","journal-title":"Journal of Translational Medicine"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0215","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/nbdi.1996.0124","article-title":"Developmental features of human striatal tissue transplanted in a rat model of Huntington's disease","volume":"3","author":"Grasbon-Frodl","year":"1997","journal-title":"Neurobiology of Disease"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.002_bb0220","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.48.6.1578","article-title":"[11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease: Implications for the symptomatic threshold","volume":"48","author":"Guttman","year":"1997","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2018.10.002_bb0225","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jnen\/60.8.741","article-title":"Cell survival and clinical outcome following intrastriatal transplantation in Parkinson disease","volume":"60","author":"Hagell","year":"2001","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.10.002_bb0230","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.brainresbull.2004.10.013","article-title":"Dyskinesias and dopamine cell replacement in Parkinson's disease: A clinical perspective","volume":"68","author":"Hagell","year":"2005","journal-title":"Brain Research Bulletin"},{"issue":"7","key":"10.1016\/bs.irn.2018.10.002_bb0235","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nn863","article-title":"Dyskinesias following neural transplantation in Parkinson's disease","volume":"5","author":"Hagell","year":"2002","journal-title":"Nature Neuroscience"},{"issue":"Pt. 6","key":"10.1016\/bs.irn.2018.10.002_bb0240","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/brain\/122.6.1121","article-title":"Sequential bilateral transplantation in Parkinson's disease: Effects of the second graft","volume":"122","author":"Hagell","year":"1999","journal-title":"Brain"},{"issue":"Pt. 3","key":"10.1016\/bs.irn.2018.10.002_bb0245","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/brain\/124.3.558","article-title":"Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa","volume":"124","author":"Haslinger","year":"2001","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0250","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archneur.56.2.179","article-title":"Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease","volume":"56","author":"Hauser","year":"1999","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0255","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1212\/WNL.58.5.687","article-title":"Bilateral human fetal striatal transplantation in Huntington's disease","volume":"58","author":"Hauser","year":"2002","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2018.10.002_bb0260","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.37.9.1441","article-title":"The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington's disease","volume":"37","author":"Hayden","year":"1987","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2018.10.002_bb0265","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00415-014-7350-7","article-title":"Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington's disease","volume":"261","author":"Herben-Dekker","year":"2014","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0270","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0014-4886(92)90181-O","article-title":"Eighteen-month course of two patients with grafts of fetal dopamine neurons for severe Parkinson's disease","volume":"118","author":"Hoffer","year":"1992","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.irn.2018.10.002_bb0275","first-page":"A126","article-title":"Dopaminergic alterationin Parkinson's patients with off-period dyskinesia following striatal embryonic mesencephalic transplant","volume":"60","author":"Huang","year":"2003","journal-title":"Neurology"},{"issue":"Suppl. 3","key":"10.1016\/bs.irn.2018.10.002_bb0280","article-title":"Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells","volume":"53","author":"Isacson","year":"2003","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2018.10.002_bb0285","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1085\/jgp.43.2.323","article-title":"Studies on the role of N-acetylaspartic acid in mammalian brain","volume":"43","author":"Jacobson","year":"1959","journal-title":"The Journal of General Physiology"},{"issue":"Pt. 4","key":"10.1016\/bs.irn.2018.10.002_bb0290","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/brain\/118.4.913","article-title":"Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects","volume":"118","author":"Jahanshahi","year":"1995","journal-title":"Brain"},{"issue":"24","key":"10.1016\/bs.irn.2018.10.002_bb0295","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1212\/01.wnl.0000264504.14301.f5","article-title":"Neural transplantation in Huntington disease: Long-term grafts in two patients","volume":"68","author":"Keene","year":"2007","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jamaneurol.2013.4749","article-title":"Long-term clinical outcome of fetal cell transplantation for Parkinson disease: Two case reports","volume":"71","author":"Kefalopoulou","year":"2014","journal-title":"JAMA Neurology"},{"issue":"7","key":"10.1016\/bs.irn.2018.10.002_bb0305","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jnr.21972","article-title":"Striatal transplantation in a rodent model of multiple system atrophy: Effects on L-Dopa response","volume":"87","author":"Kollensperger","year":"2009","journal-title":"Journal of Neuroscience Research"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0310","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nature Medicine"},{"issue":"16","key":"10.1016\/bs.irn.2018.10.002_bb0315","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/mds.22369","article-title":"Transplanted dopaminergic neurons develop PD pathologic changes: A second case report","volume":"23","author":"Kordower","year":"2008","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0320","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/mds.870130303","article-title":"Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease","volume":"13","author":"Kordower","year":"1998","journal-title":"Movement Disorders"},{"issue":"17","key":"10.1016\/bs.irn.2018.10.002_bb0325","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199504273321702","article-title":"Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease","volume":"332","author":"Kordower","year":"1995","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0330","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/(SICI)1096-9861(19960624)370:2<203::AID-CNE6>3.0.CO;2-6","article-title":"Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies","volume":"370","author":"Kordower","year":"1996","journal-title":"The Journal of Comparative Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1759-1961.2011.00018.x","article-title":"Immune response after striatal engraftment of fetal neuronal cells in patients with Huntington's disease: Consequences for cerebral transplantation programs","volume":"2","author":"Krebs","year":"2011","journal-title":"Clinical and Experimental Neuroimmunology"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0340","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.53.5.1000","article-title":"Influence of lamotrigine on progression of early Huntington disease: A randomized clinical trial","volume":"53","author":"Kremer","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000166","article-title":"Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease","volume":"2","author":"Krystkowiak","year":"2007","journal-title":"PLoS One"},{"issue":"Pt. 5","key":"10.1016\/bs.irn.2018.10.002_bb0350","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","article-title":"Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease","volume":"113","author":"Kuwert","year":"1990","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0355","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870070103","article-title":"Core assessment program for intracerebral transplantations (CAPIT)","volume":"7","author":"Langston","year":"1992","journal-title":"Movement Disorders"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.002_bb0360","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11910-017-0807-1","article-title":"Restorative strategies in movement disorders: The contribution of imaging","volume":"17","author":"Lao-Kaim","year":"2017","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0365","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.clpt.6100386","article-title":"Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy","volume":"83","author":"Lee","year":"2008","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0370","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.23612","article-title":"A randomized trial of mesenchymal stem cells in multiple system atrophy","volume":"72","author":"Lee","year":"2012","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0375","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease","volume":"47","author":"Lee","year":"2000","journal-title":"Annals of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.002_bb0380","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.1990.00530120034007","article-title":"The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease","volume":"47","author":"Leenders","year":"1990","journal-title":"Archives of Neurology"},{"issue":"1\u20134 Pt. 2","key":"10.1016\/bs.irn.2018.10.002_bb0385","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000099859","article-title":"Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients","volume":"69","author":"Levivier","year":"1997","journal-title":"Stereotactic and Functional Neurosurgery"},{"issue":"16","key":"10.1016\/bs.irn.2018.10.002_bb0390","first-page":"1272","article-title":"Stem cell transplantation for treating Parkinson's disease: Literature analysis based on the web of science","volume":"7","author":"Li","year":"2012","journal-title":"Neural Regeneration Research"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0395","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nature Medicine"},{"issue":"4942","key":"10.1016\/bs.irn.2018.10.002_bb0400","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.2105529","article-title":"Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease","volume":"247","author":"Lindvall","year":"1990","journal-title":"Science"},{"key":"10.1016\/bs.irn.2018.10.002_bb0405","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0079-6123(00)27014-3","article-title":"Clinical observations after neural transplantation in Parkinson's disease","volume":"127","author":"Lindvall","year":"2000","journal-title":"Progress in Brain Research"},{"issue":"7097","key":"10.1016\/bs.irn.2018.10.002_bb0410","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nature04960","article-title":"Stem cells for the treatment of neurological disorders","volume":"441","author":"Lindvall","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.002_bb0415","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archneur.1989.00520420033021","article-title":"Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up","volume":"46","author":"Lindvall","year":"1989","journal-title":"Archives of Neurology"},{"issue":"8626\u20138627","key":"10.1016\/bs.irn.2018.10.002_bb0420","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(88)90950-6","article-title":"Fetal dopamine-rich mesencephalic grafts in Parkinson's disease","volume":"2","author":"Lindvall","year":"1988","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0425","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ana.10359","article-title":"Dyskinesia after fetal cell transplantation for parkinsonism: A PET study","volume":"52","author":"Ma","year":"2002","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2018.10.002_bb0430","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/bmb\/ldr040","article-title":"Dopamine cell transplantation in Parkinson's disease: Challenge and perspective","volume":"100","author":"Ma","year":"2011","journal-title":"British Medical Bulletin"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0435","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2967\/jnumed.109.066811","article-title":"Dopamine cell implantation in Parkinson's disease: Long-term clinical and (18)F-FDOPA PET outcomes","volume":"51","author":"Ma","year":"2010","journal-title":"Journal of Nuclear Medicine"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.002_bb0440","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/archneur.1990.00530120025005","article-title":"Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of parkinsonian subjects","volume":"47","author":"Madrazo","year":"1990","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.002_bb0445","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3727\/096368912X658809","article-title":"Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington's disease","volume":"22","author":"McLeod","year":"2013","journal-title":"Cell Transplantation"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0450","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3171\/jns.2002.96.3.0589","article-title":"Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: A pilot study. Report of three cases","volume":"96","author":"Mendez","year":"2002","journal-title":"Journal of Neurosurgery"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0455","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nm1752","article-title":"Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years","volume":"14","author":"Mendez","year":"2008","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0460","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1136\/jnnp.64.3.314","article-title":"Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET","volume":"64","author":"Morrish","year":"1998","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"Pt. 6","key":"10.1016\/bs.irn.2018.10.002_bb0465","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/brain\/119.6.2097","article-title":"Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease","volume":"119","author":"Morrish","year":"1996","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0470","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.1075","article-title":"Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease","volume":"50","author":"Nakamura","year":"2001","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.002_bb0475","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4329\/wjr.v6.i6.301","article-title":"Neuroimaging in Huntington's disease","volume":"6","author":"Niccolini","year":"2014","journal-title":"World Journal of Radiology"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0480","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.10720","article-title":"A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease","volume":"54","author":"Olanow","year":"2003","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0485","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/0306-4522(95)00325-D","article-title":"Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence","volume":"69","author":"Olsson","year":"1995","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0490","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2018.10.002_bb0495","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jnnp-2013-306533","article-title":"Fetal striatal grafting slows motor and cognitive decline of Huntington's disease","volume":"85","author":"Paganini","year":"2014","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0500","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.24859","article-title":"Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies","volume":"81","author":"Pagano","year":"2017","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0505","doi-asserted-by":"crossref","first-page":"371","DOI":"10.7861\/clinmedicine.16-4-371","article-title":"Imaging in Parkinson's disease","volume":"16","author":"Pagano","year":"2016","journal-title":"Clinical Medicine (London, England)"},{"issue":"4393","key":"10.1016\/bs.irn.2018.10.002_bb0510","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.571147","article-title":"Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system","volume":"204","author":"Perlow","year":"1979","journal-title":"Science"},{"issue":"Pt. 3","key":"10.1016\/bs.irn.2018.10.002_bb0515","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/brain\/117.3.487","article-title":"Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon","volume":"117","author":"Peschanski","year":"1994","journal-title":"Brain"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.002_bb0520","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/16060","article-title":"Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient","volume":"2","author":"Piccini","year":"1999","journal-title":"Nature Neuroscience"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0525","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N","article-title":"Delayed recovery of movement-related cortical function in Parkinson's disease after striatal dopaminergic grafts","volume":"48","author":"Piccini","year":"2000","journal-title":"Annals of Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0530","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10526","article-title":"Endogenous dopamine release after pharmacological challenges in Parkinson's disease","volume":"53","author":"Piccini","year":"2003","journal-title":"Annals of Neurology"},{"issue":"Pt. 12","key":"10.1016\/bs.irn.2018.10.002_bb0535","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1093\/brain\/awh649","article-title":"Factors affecting the clinical outcome after neural transplantation in Parkinson's disease","volume":"128","author":"Piccini","year":"2005","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0540","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00259-005-0032-z","article-title":"Long-term assessment of striatal dopamine transporters in parkinsonian patients with intrastriatal embryonic mesencephalic grafts","volume":"33","author":"Pogarell","year":"2006","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"key":"10.1016\/bs.irn.2018.10.002_bb0545","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1741-7015-8-80","article-title":"Dyskinesias after neural transplantation in Parkinson's disease: What do we know and what is next?","volume":"8","author":"Politis","year":"2010","journal-title":"BMC Medicine"},{"key":"10.1016\/bs.irn.2018.10.002_bb0550","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrneurol.2014.205","article-title":"Neuroimaging in Parkinson disease: From research setting to clinical practice","volume":"10","author":"Politis","year":"2014","journal-title":"Nature Reviews Neurology"},{"key":"10.1016\/bs.irn.2018.10.002_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-10-1","article-title":"Clinical application of stem cell therapy in Parkinson's disease","volume":"10","author":"Politis","year":"2012","journal-title":"BMC Medicine"},{"key":"10.1016\/bs.irn.2018.10.002_bb0560","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1100\/2011\/172893","article-title":"Serotonergic dysfunction in Parkinson's disease and its relevance to disability","volume":"11","author":"Politis","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/bs.irn.2018.10.002_bb0565","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2014.07.037","article-title":"Serotonin in Parkinson's disease","volume":"277","author":"Politis","year":"2015","journal-title":"Behavioural Brain Research"},{"issue":"11","key":"10.1016\/bs.irn.2018.10.002_bb0570","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/mds.23743","article-title":"Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin\/dopamine transporter ratio","volume":"26","author":"Politis","year":"2011","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2018.10.002_bb0575","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0079-6123(10)84010-5","article-title":"Brain imaging after neural transplantation","volume":"184","author":"Politis","year":"2010","journal-title":"Progress in Brain Research"},{"key":"10.1016\/bs.irn.2018.10.002_bb0580","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/B978-0-444-59575-1.00009-0","article-title":"In vivo imaging of the integration and function of nigral grafts in clinical trials","volume":"200","author":"Politis","year":"2012","journal-title":"Progress in Brain Research"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0585","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1172\/JCI71640","article-title":"Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients","volume":"124","author":"Politis","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"issue":"128","key":"10.1016\/bs.irn.2018.10.002_bb0590","doi-asserted-by":"crossref","first-page":"128ra141","DOI":"10.1126\/scitranslmed.3003391","article-title":"Serotonin neuron loss and nonmotor symptoms continue in Parkinson's patients treated with dopamine grafts","volume":"4","author":"Politis","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"38","key":"10.1016\/bs.irn.2018.10.002_bb0595","doi-asserted-by":"crossref","first-page":"38ra46","DOI":"10.1126\/scitranslmed.3000976","article-title":"Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants","volume":"2","author":"Politis","year":"2010","journal-title":"Science Translational Medicine"},{"key":"10.1016\/bs.irn.2018.10.002_bb0600","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuint.2017.01.016","article-title":"Is there a place for human fetal-derived stem cells for cell replacement therapy in Huntington's disease?","volume":"106","author":"Precious","year":"2017","journal-title":"Neurochemistry International"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.002_bb0605","first-page":"3295","article-title":"NADPH-diaphorase histochemistry and functional analysis of human fetal striatal brain tissue transplanted into a rodent model of Huntington's disease","volume":"26","author":"Pundt","year":"1994","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0610","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mds.870110205","article-title":"Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT-HD)","volume":"11","author":"Quinn","year":"1996","journal-title":"Movement Disorders"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0615","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/archneur.1992.00530260044017","article-title":"Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine","volume":"49","author":"Rascol","year":"1992","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2018.10.002_bb0620","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jnnp.57.5.567","article-title":"Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa","volume":"57","author":"Rascol","year":"1994","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0625","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.410380406","article-title":"Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients","volume":"38","author":"Remy","year":"1995","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0630","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3892\/etm.2016.3392","article-title":"Neural stem cell transplantation for the treatment of primary torsion dystonia: A case report","volume":"12","author":"Ren","year":"2016","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"8","key":"10.1016\/bs.irn.2018.10.002_bb0635","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/jnnp.2007.142380","article-title":"Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease","volume":"79","author":"Reuter","year":"2008","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0640","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1099-1492(199906)12:4<221::AID-NBM582>3.0.CO;2-Q","article-title":"In vivo magnetic resonance spectroscopy of human fetal neural transplants","volume":"12","author":"Ross","year":"1999","journal-title":"NMR in Biomedicine"},{"issue":"6","key":"10.1016\/bs.irn.2018.10.002_bb0645","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/jnnp.73.6.678","article-title":"Unilateral transplantation of human primary fetal tissue in four patients with Huntington's disease: NEST-UK safety report ISRCTN no 36485475","volume":"73","author":"Rosser","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.002_bb0650","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/WNL.0000000000002494","article-title":"Serotonin-to-dopamine transporter ratios in Parkinson disease: Relevance for dyskinesias","volume":"86","author":"Roussakis","year":"2016","journal-title":"Neurology"},{"issue":"Pt. 2","key":"10.1016\/bs.irn.2018.10.002_bb0655","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/brain\/awf036","article-title":"Attention to action in Parkinson's disease: Impaired effective connectivity among frontal cortical regions","volume":"125","author":"Rowe","year":"2002","journal-title":"Brain"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0660","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.410310207","article-title":"Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants","volume":"31","author":"Sawle","year":"1992","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2018.10.002_bb0665","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bbr.2013.07.053","article-title":"Donor age dependent graft development and recovery in a rat model of Huntington's disease: Histological and behavioral analysis","volume":"256","author":"Schackel","year":"2013","journal-title":"Behavioural Brain Research"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0670","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.nbd.2012.03.038","article-title":"Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease","volume":"47","author":"Shin","year":"2012","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0675","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ana.410340304","article-title":"Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels","volume":"34","author":"Snow","year":"1993","journal-title":"Annals of Neurology"},{"issue":"22","key":"10.1016\/bs.irn.2018.10.002_bb0680","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJM199211263272201","article-title":"Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease","volume":"327","author":"Spencer","year":"1992","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"10.1016\/bs.irn.2018.10.002_bb0685","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00259-009-1103-3","article-title":"Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins","volume":"36","author":"Squitieri","year":"2009","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0690","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0304-3940(86)90632-4","article-title":"Human fetal substantia nigra grafted to the dopamine-denervated striatum of immunosuppressed rats: Evidence for functional reinnervation","volume":"71","author":"Stromberg","year":"1986","journal-title":"Neuroscience Letters"},{"issue":"19","key":"10.1016\/bs.irn.2018.10.002_bb0695","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.0b013e3181fc27e4","article-title":"Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease","volume":"75","author":"Sturrock","year":"2010","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/bs.irn.2018.10.002_bb0700","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1046\/j.1460-9568.1998.00378.x","article-title":"Growth\/differentiation factor 5 and glial cell line-derived neurotrophic factor enhance survival and function of dopaminergic grafts in a rat model of Parkinson's disease","volume":"10","author":"Sullivan","year":"1998","journal-title":"The European Journal of Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0705","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.parkreldis.2012.07.018","article-title":"fMRI changes in cortical activation during task performance with the unaffected hand partially reverse after ropinirole treatment in de novo Parkinson's disease","volume":"19","author":"Tessa","year":"2013","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0710","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3727\/096368916X694373","article-title":"Treatment of spinocerebellar ataxia with mesenchymal stem cells: A phase I\/IIa clinical study","volume":"26","author":"Tsai","year":"2017","journal-title":"Cell Transplantation"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.10.002_bb0715","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0006-8993(99)01834-X","article-title":"Is synaptic dopamine concentration the exclusive factor which alters the in vivo binding of [11C]raclopride?: PET studies combined with microdialysis in conscious monkeys","volume":"841","author":"Tsukada","year":"1999","journal-title":"Brain Research"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0720","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.410410111","article-title":"Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?","volume":"41","author":"Vingerhoets","year":"1997","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0725","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/exnr.1999.7341","article-title":"Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease","volume":"163","author":"Watts","year":"2000","journal-title":"Experimental Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0730","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0735","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ana.410420115","article-title":"Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease","volume":"42","author":"Wenning","year":"1997","journal-title":"Annals of Neurology"},{"issue":"22","key":"10.1016\/bs.irn.2018.10.002_bb0740","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1056\/NEJM199211263272203","article-title":"Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"327","author":"Widner","year":"1992","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.irn.2018.10.002_bb0745","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00011","article-title":"Molecular imaging markers to track Huntington's disease pathology","volume":"8","author":"Wilson","year":"2017","journal-title":"Frontiers in Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.10.002_bb0750","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3171\/jns.2005.102.1.0080","article-title":"Early transplantation of an encapsulated glial cell line-derived neurotrophic factor-producing cell demonstrating strong neuroprotective effects in a rat model of Parkinson disease","volume":"102","author":"Yasuhara","year":"2005","journal-title":"Journal of Neurosurgery"},{"issue":"2","key":"10.1016\/bs.irn.2018.10.002_bb0755","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/JHD-160191","article-title":"A longitudinal motor characterisation of the HdhQ111 mouse model of Huntington's disease","volume":"5","author":"Yhnell","year":"2016","journal-title":"The Journal of Huntington's Disease"},{"issue":"3","key":"10.1016\/bs.irn.2018.10.002_bb0760","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410200305","article-title":"PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline","volume":"20","author":"Young","year":"1986","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2018.10.002_bb0765","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/bs.irn.2017.02.015","article-title":"Imaging in Parkinson's Disease","volume":"132","author":"Politis","year":"2017","journal-title":"International Review of Neurobiology"},{"issue":"4","key":"10.1016\/bs.irn.2018.10.002_bb0770","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3233\/JHD-150171","article-title":"PET imaging in Huntington's disease","volume":"4","author":"Roussakis","year":"2015","journal-title":"The Journal of Huntington's Disease"}],"container-title":["International Review of Neurobiology","Imaging in Movement Disorders: Imaging Applications in Non-Parkinsonian and Other Movement Disorders"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774218301314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774218301314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T07:32:36Z","timestamp":1543303956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774218301314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":153,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2018.10.002","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}